H. Koponen et al., CITALOPRAM IN THE TREATMENT OF OBSESSIVE-COMPULSIVE DISORDER - AN OPEN PILOT-STUDY, Acta psychiatrica Scandinavica, 96(5), 1997, pp. 343-346
Obsessive-compulsive disorder (OCD) is a common anxiety disorder, whic
h often causes significant impairment of the affected individual's soc
ial, occupational or interpersonal functioning. Previous reports sugge
st that the disorder may be treated with the tricyclic antidepressant
clomipramine, and also with the more recently introduced selective ser
otonin reuptake inhibitors (SSRIs), such as fluoxetine, fluvoxamine, s
ertraline and paroxetine. The present 24-week open pilot study was des
igned to examine the efficacy, appropriate dose range, side-effects an
d clinical usefulness of citalopram in OCD. A total of 29 OCD patients
were included in the study, of whom 76% showed alleviation of symptom
s as evaluated by various self- and observer-rated scales, such as the
Yale-Brown Obsessive Compulsive Scale. In most cases the citalopram d
oses used were in most cases 40 or 60 mg daily, and the treatment was
well tolerated. The most commonly experienced adverse events during th
e study were nausea, vomiting, increased dreaming and decreased sleep.
Diminished sexual desire and orgasmic dysfunction were also reported.
Despite having the limitations of an open study, our results suggest
that citalopram may be effective in the treatment of obsessive-compuls
ive disorder.